SG170065A1 - Human embryonic stem cell methods and podxl expression - Google Patents

Human embryonic stem cell methods and podxl expression

Info

Publication number
SG170065A1
SG170065A1 SG201101522-9A SG2011015229A SG170065A1 SG 170065 A1 SG170065 A1 SG 170065A1 SG 2011015229 A SG2011015229 A SG 2011015229A SG 170065 A1 SG170065 A1 SG 170065A1
Authority
SG
Singapore
Prior art keywords
embryonic stem
human embryonic
cells
stem cell
cell
Prior art date
Application number
SG201101522-9A
Other languages
English (en)
Inventor
Andre Choo
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG170065A1 publication Critical patent/SG170065A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
SG201101522-9A 2006-03-06 2007-03-06 Human embryonic stem cell methods and podxl expression SG170065A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77891306P 2006-03-06 2006-03-06

Publications (1)

Publication Number Publication Date
SG170065A1 true SG170065A1 (en) 2011-04-29

Family

ID=38475152

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101522-9A SG170065A1 (en) 2006-03-06 2007-03-06 Human embryonic stem cell methods and podxl expression

Country Status (9)

Country Link
US (2) US8173374B2 (fr)
EP (2) EP1994144B1 (fr)
JP (1) JP5507086B2 (fr)
CN (1) CN101454441B (fr)
AU (1) AU2007222165A1 (fr)
CA (1) CA2644856A1 (fr)
IL (1) IL193883A0 (fr)
SG (1) SG170065A1 (fr)
WO (1) WO2007102787A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG170065A1 (en) 2006-03-06 2011-04-29 Agency Science Tech & Res Human embryonic stem cell methods and podxl expression
US20110003710A1 (en) * 2008-02-28 2011-01-06 John Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
SG160248A1 (en) * 2008-09-18 2010-04-29 Agency Science Tech & Res Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
EP2442106B1 (fr) * 2009-06-10 2015-08-19 Masanori Hara Méthode de détection d'une néphropathie diabétique
CA2766164A1 (fr) * 2009-06-25 2010-12-29 Geron Corporation Descendance de cellules souches pluripotentes differenciees appauvrie en phenotypes etrangers
WO2011004837A1 (fr) * 2009-07-08 2011-01-13 株式会社ＡＣＴＧｅｎ Anticorps ayant une activité anticancéreuse
JP5785948B2 (ja) 2009-09-04 2015-09-30 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 胚性幹細胞におけるゲノムの安定性およびテロメアの伸長を促進するための方法
EP2315028A1 (fr) 2009-10-26 2011-04-27 Atlas Antibodies AB Protéine PODXL dans le cancer colorectal
EP2531853B1 (fr) * 2010-02-04 2015-06-10 Agency For Science, Technology And Research Utilisation de nouveaux marqueurs de cellules souches pluripotentes
WO2012011876A1 (fr) * 2010-07-21 2012-01-26 Agency For Science, Technology And Research Procédés d'identification de molécules d'anticorps cytotoxiques candidates
WO2012056997A1 (fr) 2010-10-28 2012-05-03 国立大学法人熊本大学 Procédé et milieu de culture pour améliorer l'efficacité d'induction de différenciation de cellules souches pluripotentes
EP2758430A4 (fr) * 2011-09-20 2015-06-03 Lilly Co Eli Anticorps anti-c-met
EP2746768A1 (fr) * 2012-12-20 2014-06-25 Atlas Antibodies AB Podxl dans le cancer de la vessie
JP6742581B2 (ja) * 2012-12-21 2020-08-19 学校法人立命館 標的細胞障害活性を有するｉＰＳ／ＥＳ細胞特異的抗体及びその用途
CN103204919B (zh) * 2013-03-29 2014-10-08 浙江大学 胚胎干细胞特异性标志物Aire及其应用
EP3060580B1 (fr) 2013-10-21 2021-03-31 Centre For Drug Research And Development Anticorps anti-podocalyxine et leurs méthodes d'utilisation
SG11201604503XA (en) 2013-12-03 2016-07-28 Agency Science Tech & Res Cytotoxic antibody
EP3690055A1 (fr) 2014-01-14 2020-08-05 Kagoshima University Procédé d'étiquetage d'une cellule responsable de la cancérisation dans des cellules souches
SG11201703544QA (en) * 2014-11-07 2017-06-29 Univ Osaka Differentiation-induced cell population from which undifferentiated cells have been removed, use of same, and method for producing same
CA3000242A1 (fr) 2015-10-01 2017-04-06 The Centre For Drug Research And Development Anticorps anti-podocalyxine et leurs methodes d'utilisation
WO2018181342A1 (fr) * 2017-03-28 2018-10-04 味の素株式会社 Additif pour milieu de maintien de dédifférenciation
WO2020139914A1 (fr) * 2018-12-26 2020-07-02 Academia Sinica Méthodes de régulation d'activité de cellules souches pluripotentes et leurs applications

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
RU2170257C2 (ru) * 1994-03-17 2001-07-10 Мерк Патент Гмбх Анти-эфрр одноцепочечный fv, химерное анти-эфрр антитело и способ его получения, фармацевтическая композиция для лечения опухолей, средство для диагностики локализации или оценки роста опухоли
GB9717946D0 (en) * 1997-08-22 1997-10-29 Imp Cancer Res Tech Novel chemical entity
AU2978899A (en) 1998-03-03 1999-09-20 Abgenix, Inc. Cd147 binding molecules as therapeutics
US7413904B2 (en) * 1998-10-23 2008-08-19 Geron Corporation Human embryonic stem cells having genetic modifications
MXPA04005010A (es) * 2001-11-26 2005-04-08 Advanced Cell Tech Inc METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS.
US20050281828A1 (en) * 2003-03-04 2005-12-22 Bowdish Katherine S Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
US20030224411A1 (en) * 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
US7833733B2 (en) * 2003-06-09 2010-11-16 The University Of British Columbia Methods for detecting and treating cancer
US20050233446A1 (en) 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
US20060182724A1 (en) * 2005-02-15 2006-08-17 Riordan Neil H Method for expansion of stem cells
CN103113463B (zh) 2005-12-13 2015-02-18 国立大学法人京都大学 核重新编程因子
SG170065A1 (en) * 2006-03-06 2011-04-29 Agency Science Tech & Res Human embryonic stem cell methods and podxl expression
US20060294607A1 (en) 2006-03-29 2006-12-28 Applera Corporation Human podocalyxin alternative-spliced forms and uses thereof
WO2007149926A1 (fr) 2006-06-20 2007-12-27 Wisconsin Alumni Research Foundation Procédé de culture de cellules souches
US8968994B2 (en) 2006-07-06 2015-03-03 Jeremy Micah Crook Method for stem cell culture and cells derived therefrom

Also Published As

Publication number Publication date
AU2007222165A1 (en) 2007-09-13
EP1994144A1 (fr) 2008-11-26
CN101454441B (zh) 2013-06-26
US8710190B2 (en) 2014-04-29
CA2644856A1 (fr) 2007-09-13
WO2007102787A1 (fr) 2007-09-13
EP1994144A4 (fr) 2009-09-09
IL193883A0 (en) 2011-08-01
JP5507086B2 (ja) 2014-05-28
CN101454441A (zh) 2009-06-10
EP3275901A1 (fr) 2018-01-31
US20090214490A1 (en) 2009-08-27
EP3275901A8 (fr) 2018-03-21
EP3275901B1 (fr) 2020-07-15
US8173374B2 (en) 2012-05-08
US20120219962A1 (en) 2012-08-30
JP2009528838A (ja) 2009-08-13
EP1994144B1 (fr) 2017-11-22

Similar Documents

Publication Publication Date Title
SG170065A1 (en) Human embryonic stem cell methods and podxl expression
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
MX2008009886A (es) Anticuerpos que enlazan par-2.
WO2006124641A3 (fr) Anticorps diriges contre la mesotheline utiles pour des dosages immunologiques
WO2006105152A3 (fr) Compositions a base de cellules amniotiques, methodes de production et utilisations desdites compositions
WO2005047524A3 (fr) Compositions et procedes pour induire la differenciation cellulaire
WO2007084321A3 (fr) Anticorps dirigés contre ox-2/cd200 et utilisations correspondantes
WO2006076691A3 (fr) Anticorps 2 associes a la translocation de recepteur immunitaire (irta-2) et leurs utilisations
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
SG170080A1 (en) Human monoclonal antibodies to o8e
EP2534257A4 (fr) Procédés d'identification et d'isolement de cellules exprimant un polypeptide
WO2008118392A3 (fr) Plate-formes synthétiques de cellules et leurs procédés d'utilisation
MX342595B (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos.
EA200800229A1 (ru) Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1)
WO2009126655A3 (fr) Reprogrammation d’une cellule par induction d’un gène pluripotent par utilisation d’un modulateur à petite molécule
WO2006087220A3 (fr) Récipient pour séparer des cellules tumorales
WO2005097185A3 (fr) Anticorps irta-5 et utilisations de ces derniers
WO2007114986A3 (fr) Sondes coopératives et leurs procédés d'utilisation
PL2183599T3 (pl) Wysoko specyficzny test immunologiczny i zestaw do oznaczania peptydów i białek o znaczeniu biologicznym
WO2007028079A3 (fr) Procedes de stimulation de l'expansion de cellules souches hematopoietiques
CA2735138C (fr) Procedes de criblage pour lesion pulmonaire aigue associee a une transfusion (trali)
WO2011096894A3 (fr) Utilisation de nouveaux marqueurs de cellules souches pluripotentes
PT2294176T (pt) Adaptador de câmara de amostra, em particular para a criopreservação de amostras biológicas
ATE414277T1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests